SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001607062-21-000299
Filing Date
2021-08-27
Accepted
2021-08-26 19:05:57
Documents
55
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rgbp063021form10q.htm   iXBRL 10-Q 2415088
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 9502
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 9481
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 4227
5 EXHIBIT 32.2 ex32_2.htm EX-32.2 4098
  Complete submission text file 0001607062-21-000299.txt   6672752

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE rgbp-20210630.xsd EX-101.SCH 57030
7 XBRL CALCULATION FILE rgbp-20210630_cal.xml EX-101.CAL 47592
8 XBRL DEFINITION FILE rgbp-20210630_def.xml EX-101.DEF 173303
9 XBRL LABEL FILE rgbp-20210630_lab.xml EX-101.LAB 299860
10 XBRL PRESENTATION FILE rgbp-20210630_pre.xml EX-101.PRE 241458
11 EXTRACTED XBRL INSTANCE DOCUMENT rgbp063021form10q_htm.xml XML 950462
Mailing Address 4700 SPRING ST #304 LA MESA CA 91942
Business Address 4700 SPRING ST #304 LA MESA CA 91942 619-722-5505
Regen BioPharma Inc (Filer) CIK: 0001589150 (see all company filings)

IRS No.: 455192997 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 333-191725 | Film No.: 211213722
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences